Citistroke 2 (Citicoline SOLUTION) 250mg/2ml

Citistroke 2 is a prescription neuroprotective solution containing 250mg of citicoline per 2ml (125 mg/mL) for intravenous or intramuscular administration. Classified as a nootropic and neuroprotective agent, it acts as an intermediate in the biosynthesis of cell membrane phospholipids, particularly phosphatidylcholine. This medication helps restore brain phospholipid content and increase acetylcholine levels, supporting neurological function under hypoxic or ischemic conditions.

Strength

250mg/2ml

Pack Size

25s

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Citistroke 2 is primarily indicated for the treatment of acute stroke, cerebral infarction, and head trauma. It is also utilized to manage cognitive impairment associated with chronic cerebrovascular diseases. By supporting neuronal membrane repair and increasing neurotransmitter levels, it helps mitigate neurological deficits resulting from brain injuries or vascular events.

Side Effects

While Citistroke 2 is generally well-tolerated, some patients may experience side effects. Reported adverse effects include gastrointestinal disturbances, transient headaches, dizziness, insomnia, and fluctuations in blood pressure. Injection site reactions may also occur during intravenous or intramuscular administration.

Precautions & Warnings

Citistroke 2 is a prescription-only (Rx) medication that must be administered under medical supervision. It should not be used in patients with hypersensitivity to citicoline or any of the solution's excipients. Since its safety profile during pregnancy and lactation is not fully established, it should only be administered to pregnant or breastfeeding women if the potential benefits outweigh the risks.

Avoid Interactions

Citicoline may interact with other medications. It can potentiate the effects of L-dopa (levodopa), which may require a dosage adjustment of the latter. Additionally, Citistroke 2 should not be administered simultaneously with medicines containing meclofenoxate (centrophenoxine), as it may interfere with their therapeutic action.

Frequently Asked Questions

Citistroke 2 is a prescription neuroprotective injection used to treat acute stroke, cerebral infarction, head trauma, and cognitive impairment associated with cerebrovascular disease.

The active ingredient, citicoline, serves as an intermediate in synthesizing cell membrane phospholipids. It helps restore brain phospholipid levels, increases acetylcholine, and protects neurons during hypoxic or ischemic events.

Citistroke 2 is a solution administered via intravenous (IV) or intramuscular (IM) injection by a qualified healthcare professional.

Common side effects may include mild gastrointestinal upset, headache, dizziness, insomnia, blood pressure changes, or localized injection site irritation.

Citistroke 2 can interact with certain drugs, such as potentiating the effects of L-dopa. It should not be co-administered with meclofenoxate. Always consult a doctor regarding potential drug interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.